Marketscreener, stock market website
748dbe55d3e2ddede88d4265a99900.3V-Gu-E57iFb1vwX1bhXj2XCrIiysOWoxf-qLd9c0UU.uBXUi4xR2hMPsspznNk93xfvgePD1peQoqieZbEdggSJD7HJj2OGEgvhmw
Logo MarketScreener
To continue, log in
Back
Logo MarketScreener

Enter your password

Forgot your password ?
Subscribe
  • Markets
    Stocks
    Top Capitalization
    United States
    North America
    Europe
    Asia
    Middle East
    Sector Research
    Company Calendar
    Equity Analysis
    Most popular
    ALPHABET INC.
    MICROSOFT CORPORATION
    META PLATFORMS, INC.
    AMAZON.COM, INC.
    TESLA, INC.
    SERVICENOW, INC.
    NVIDIA CORPORATION
    Indices
    Homepage
    Rankings
    Europe
    America
    Asia
    Africa
    Index Analysis
    Indices News
    S&P 500
    DOW JONES
    NASDAQ 100
    TSX COMP
    FTSE 100
    DAX
    CAC 40
    EURO STOXX 50
    Currency / Forex
    Homepage
    Rankings
    Currency Cross Rate
    Currency Converter
    Forex Analysis
    Currencies News
    USD / EUR
    USD / CAD
    USD / MXN
    USD / BRL
    USD / INR
    Commodities
    Homepage
    Energy
    Precious metals
    Agriculture
    Industrial Metals
    Livestock and Cattle
    GOLD
    CRUDE OIL (WTI)
    CRUDE OIL (BRENT)
    SILVER
    PLATINUM
    Cryptocurrencies
    Homepage
    Rankings
    Charts
    Analysis
    News
    Logo Crypto <span class='ml-5 txt-link txt-s1'>BITCOINBITCOIN
    Logo Crypto <span class='ml-5 txt-link txt-s1'>ETHEREUMETHEREUM
    Logo Crypto <span class='ml-5 txt-link txt-s1'>BINANCE COINBINANCE COIN
    Logo Crypto <span class='ml-5 txt-link txt-s1'>SOLANASOLANA
    Logo Crypto <span class='ml-5 txt-link txt-s1'>CARDANOCARDANO
    Logo Crypto <span class='ml-5 txt-link txt-s1'>CHAINLINKCHAINLINK
    Interest Rates
    Homepage
    Yield Curve
    Developed Markets
    Emerging Markets
    ETF
    Summary
    Screener
    Analysis
    News
  • News
    All News
    Macroeconomics
    Policy
    Geopolitics
    Technology
    International Trade
    Military conflicts
    Taxation
    Sustainable development
    Legal, Regulation and Crime
    Companies
    Financial Results
    Analyst Recommendations
    Transcripts
    Press releases
    Insider transaction
    Controversies
    Innovations and expansions
    IPOs
    Rumors
    Activism
    Negative surprises
    Positive surprises
    New Contracts
    Indices
    Currency / Forex
    Commodities
    Cryptocurrencies
    ETF
    Interest Rates
    Funds
    Economy
    Sectors
    All our articles
    Most Read News
    Key News
    Business Insiders
  • Analysis
    All Articles
    Must Read
    Interviews
    Stocks
    Indices
    Currencies
    Commodities
    ETF
    Cryptocurrencies
    Interest Rates
  • Calendar
    Economic Calendar
    Company Calendar
    Dividend calendar
  • Stock Picks
    All our investments
    United States
    Europe
    Asia, Pacific
  • Portfolios
    USA Portfolio
    European Portfolio
    Asian Portfolio
    Virtual Portfolios
  • Watchlists
    My Watchlists
    Watchlists
    My previous session
    My most visited
    Most popular
    Investment Style
    Homepage
    Dividend Kings
    ESG stocks
    Yield stocks
    Growth stocks
    Growth stocks at reasonable prices
    Dividend Aristocrats
    Investment Themes
    Homepage
    Franchises
    Millennials
    Moat
    hydraulics
    Solar energy
    Strategic Metals
  • Trading
    Market Timing
    Key News
    Pre/Post-Market Movers
    Technical Alerts
  • Screeners
    Stocks
    ETF
    Insider Transactions
  • Tools
    ProRealTime Charts
    Currency Converter
  • Rankings
    Top Movers
    Short-Term Gainers & Losers
    Long-term Gainers & Losers
    Unusual Volumes
    New Historical Highs
    New Historical Lows
    Pre/Post-Market Movers
    Top Fundamentals
    Fundamental Composite
    Sales Growth
    Earnings Growth
    Profitability
    Finances
    Visibility Rankings
    Rankings Valuation
    Valuation Composite
    Market Cap
    P/E
    Enterprise Value
    Yield
    Price to Book (PBR)
    Free Cash Flow (FCF)
    Top Consensus
    Consensus Composite
    Analyst Opinion
    Target Price
    Opinion Divergences
    Estimates Revisions
    Analyst Coverage
    Technical Analysis Rankings
    RSI
    GAPS
    STIM
    Daily Breakouts
    Weekly Breakouts
    Trends
    Volatility
    Top ranking ESG
    ESG MSCI
    Environment
    Social
    Governance
    Islamic Finance
    Paris Agreement
US Edition
Subscribe
  • Homepage
  • Markets
    • Stocks
      • Top Capitalization
      • United States
      • North America
      • Europe
      • Asia
      • Middle East
      • Sector Research
      • Company Calendar
      • Equity Analysis
      • Most popular
      • ALPHABET INC.
      • MICROSOFT CORPORATION
      • META PLATFORMS, INC.
      • AMAZON.COM, INC.
      • TESLA, INC.
      • SERVICENOW, INC.
      • NVIDIA CORPORATION
    • Indices
      • Homepage
      • Rankings
      • Europe
      • America
      • Asia
      • Africa
      • Index Analysis
      • Indices News
      • S&P 500
      • DOW JONES
      • NASDAQ 100
      • TSX COMP
      • FTSE 100
      • DAX
      • CAC 40
      • EURO STOXX 50
    • Currency / Forex
      • Homepage
      • Rankings
      • Currency Cross Rate
      • Currency Converter
      • Forex Analysis
      • Currencies News
      • USD / EUR
      • USD / CAD
      • USD / MXN
      • USD / BRL
      • USD / INR
    • Commodities
      • Homepage
      • Energy
      • Precious metals
      • Agriculture
      • Industrial Metals
      • Livestock and Cattle
      • GOLD
      • CRUDE OIL (WTI)
      • CRUDE OIL (BRENT)
      • SILVER
      • PLATINUM
    • Cryptocurrencies
      • Homepage
      • Rankings
      • Charts
      • Analysis
      • News
      • Logo Crypto <span class='ml-5 txt-link txt-s1'>BITCOINBITCOIN
      • Logo Crypto <span class='ml-5 txt-link txt-s1'>ETHEREUMETHEREUM
      • Logo Crypto <span class='ml-5 txt-link txt-s1'>BINANCE COINBINANCE COIN
      • Logo Crypto <span class='ml-5 txt-link txt-s1'>SOLANASOLANA
      • Logo Crypto <span class='ml-5 txt-link txt-s1'>CARDANOCARDANO
      • Logo Crypto <span class='ml-5 txt-link txt-s1'>CHAINLINKCHAINLINK
    • Interest Rates
      • Homepage
      • Yield Curve
      • Developed Markets
      • Emerging Markets
    • ETF
      • Summary
      • Screener
      • Analysis
      • News
  • News
    • All News
      • Macroeconomics
      • Policy
      • Geopolitics
      • Technology
      • International Trade
      • Military conflicts
      • Taxation
      • Sustainable development
      • Legal, Regulation and Crime
    • Companies
      • Financial Results
      • Analyst Recommendations
      • Transcripts
      • Press releases
      • Insider transaction
      • Controversies
      • Innovations and expansions
      • IPOs
      • Rumors
      • Activism
      • Negative surprises
      • Positive surprises
      • New Contracts
    • Indices
    • Currency / Forex
    • Commodities
    • Cryptocurrencies
    • ETF
    • Interest Rates
    • Funds
    • Economy
    • Sectors
    • All our articles
    • Most Read News
    • Key News
    • Business Insiders
  • Analysis
    • All Articles
    • Must Read
    • Interviews
    • Stocks
    • Indices
    • Currencies
    • Commodities
    • ETF
    • Cryptocurrencies
    • Interest Rates
  • Calendar
    • Economic Calendar
    • Company Calendar
    • Dividend calendar
  • Stock Picks
    • All our investments
    • United States
    • Europe
    • Asia, Pacific
  • Portfolios
    • USA Portfolio
    • European Portfolio
    • Asian Portfolio
    • Virtual Portfolios
  • Watchlists
    • My Watchlists
      • Watchlists
      • My previous session
      • My most visited
      • Most popular
    • Investment Style
      • Homepage
      • Dividend Kings
      • ESG stocks
      • Yield stocks
      • Growth stocks
      • Growth stocks at reasonable prices
      • Dividend Aristocrats
    • Investment Themes
      • Homepage
      • Franchises
      • Millennials
      • Moat
      • hydraulics
      • Solar energy
      • Strategic Metals
  • Trading
    • Market Timing
    • Key News
    • Pre/Post-Market Movers
    • Technical Alerts
  • Screeners
    • Stocks
    • ETF
    • Insider Transactions
  • Tools
    • ProRealTime Charts
    • Currency Converter
  • Rankings
    • Top Movers
      • Short-Term Gainers & Losers
      • Long-term Gainers & Losers
      • Unusual Volumes
      • New Historical Highs
      • New Historical Lows
    • Pre/Post-Market Movers
    • Top Fundamentals
      • Fundamental Composite
      • Sales Growth
      • Earnings Growth
      • Profitability
      • Finances
      • Visibility Rankings
    • Rankings Valuation
      • Valuation Composite
      • Market Cap
      • P/E
      • Enterprise Value
      • Yield
      • Price to Book (PBR)
      • Free Cash Flow (FCF)
    • Top Consensus
      • Consensus Composite
      • Analyst Opinion
      • Target Price
      • Opinion Divergences
      • Estimates Revisions
      • Analyst Coverage
    • Technical Analysis Rankings
      • RSI
      • GAPS
      • STIM
      • Daily Breakouts
      • Weekly Breakouts
      • Trends
      • Volatility
    • Top ranking ESG
      • ESG MSCI
      • Environment
      • Social
      • Governance
      • Islamic Finance
      • Paris Agreement
Switch edition
Stock OTLK OUTLOOK THERAPEUTICS, INC.
Add to a list

Outlook Therapeutics, Inc.

Stocks

OTLK

US69012T3059

Biotechnology & Medical Research

Market Closed -
Nasdaq
04:00:00 2026-10-30 pm EDT
5-day change 1st Jan Change
0.4681 USD -5.15% Intraday chart for Outlook Therapeutics, Inc. -9.86% -70.37%
Oct. 11 Certain Common Stock of Outlook Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 12-OCT-2026. CI
Oct. 09 Outlook Therapeutics Names Greg DiPasquale Chief Commercial Officer MT
Summary
Quotes
Charts
Technical Analysis Static Chart News Chart Sector Chart Comparison Chart Relative Strength Chart
News
All News Broker Recommendations Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies
Company
Profile Governance Share ownership Insider Transactions Connections
Financials
Analysts' Forecasts Income Statement Balance Sheet Cash flow Financial Ratios Business Segments
Valuation
Consensus
Analysts' Opinion Estimates Revisions
Ratings
Calendar
Sector
Sector performance Sector valuations Sector dividends Financial comparisons Sector ratings Sector consensus Sector revisions
ETFs
All News Broker Recommendations Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies

Top Premarket Decliners

Published on 08/13/2026 at 07:41 am EDT

MT Newswires
This article is reserved for our members.
Log in to continue
Continue with Google Continue with Apple Continue with LinkedIn
or by email
Continue with an email.
Create an account with Google Create an account with Apple Create an account with LinkedIn
or by email
Create an account
For unlimited access, Check out our subscriptions.

Latest news about Outlook Therapeutics, Inc.

Oct. 11 Certain Common Stock of Outlook Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 12-OCT-2026. CI
Oct. 09 Outlook Therapeutics Names Greg DiPasquale Chief Commercial Officer MT
Oct. 09 Outlook Therapeutics, Inc. Announces Appointment of Greg DiPasquale as Chief Commercial Officer CI
Oct. 01 Outlook Therapeutics, Inc. Submits HCPCS Level II Application To CMS For Permanent J-Code For LYTENAVA CI
Sep. 20 Outlook Therapeutics, Inc.(NasdaqCM:OTLK) added to S&P Global BMI Index CI
Aug. 27 Outlook Therapeutics, Inc. Announces CFO Changes, Effective September 1, 2026 CI
Aug. 27 Outlook Therapeutics Appoints Kevin Lundquist as CFO MT
Aug. 27 Outlook Therapeutics, Inc. Announces Management Changes, Effective September 1, 2026 CI
Aug. 17 EyePoint's drug for age-related eye disease fails late-stage trial, shares tank RE
Aug. 17 Outlook Therapeutics Insider Bought Shares Worth $2,499,999, According to a Recent SEC Filing MT
Aug. 14 Outlook Therapeutics, Inc., Q3 2026 Earnings Call, Aug 14, 2026
Aug. 14 Outlook Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2026 CI
Aug. 13 Top Premarket Decliners MT
Aug. 13 Outlook Therapeutics Prices $55 Million Securities Offering; Shares Down Pre-Bell MT
Aug. 12 Outlook Therapeutics Starts Public Offering of Stock, Warrants MT

Chart Outlook Therapeutics, Inc.

Chart Outlook Therapeutics, Inc.
OTLK: Dynamic Chart

Company Profile

Logo Outlook Therapeutics, Inc.
Outlook Therapeutics, Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing ONS-5010/LYTENAVA (bevacizumab-gamma), an ophthalmic formulation of bevacizumab for use in retinal indications. It is advancing ONS-5010 / LYTENAVA (bevacizumab-vikg), an investigational ophthalmic formulation of bevacizumab for the treatment of wet age-related macular degeneration (wet AMD), diabetic macular edema (DME), and branch retinal vein occlusion (BRVO). Bevacizumab-vikg is a recombinant humanized monoclonal antibody (mAb) that selectively binds with high affinity to all isoforms of human vascular endothelial growth factor (VEGF) and neutralizes VEGF’s biologic activity through a steric blocking of the binding of VEGF to its receptors Flt-1 (VEGFR-1) and KDR (VEGFR-2) on the surface of endothelial cells. ONS-5010/LYTENAVA, consisted of three clinical trials which it refers to as NORSE ONE, NORSE TWO and NORSE THREE.
Employees
17
Sector
Biotechnology & Medical Research
More about the company

Income Statement and Estimates

Projected Income Statement - Annual - Outlook Therapeutics, Inc.
More financial data

Ratings

Trader

Trader

This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.

Investor

Investor

This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.

-
Global

Global

This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.

-
Quality

Quality

This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.

-
ESG MSCI

ESG MSCI

The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

-
MarketScreener Ratings - Outlook Therapeutics, Inc.
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
0.4681USD
Average target price
5.025USD
Spread / Average Target
+973.49%
Consensus
EPS Estimates
Evolution of Analysts' Estimates - EPS - Outlook Therapeutics, Inc.
Revisions to estimates
Indices Europe America Asia

 

 
 
 
My Watchlist
 

My lists
Rankings
 

More Rankings
Rankings
 

More Rankings

Currency / Forex

Commodities

Cryptocurrencies

Interest Rates

  1. Stock Market
  2. Stock Market News
  3. Top Premarket Decliners
Best financial portal

Best financial
portal

More than 20 yearsat your side

More than 20 years
at your side

Trustpilot
1,300,000 +members

1,300,000 +
members

Quick & easycancellation

Quick & easy
cancellation

Our Expertsare here for you

Our Experts
are here for you

Download from Apple Store

OUR EXPERTS ARE HERE FOR YOU

+1 (951) 669-7394

Contact us
MarketScreener, Stock Market Live
Legal information | Cookie settings | MarketScreener Blog | About us | Copyright © 2026 Surperformance SAS. All rights reserved.
Stock quotes are provided by Factset, Morningstar and S&P Capital IQ
Stock markets for all
100% Free Registration
100% Free Registration
DAILY FREE LIMIT REACHED
To continue browsing,
Sign up!
Extended daily access
Personal watchlists and screeners
Real-time market news
Access the "Discovery" Stock Screener (covering 30,000 companies)
Create your free account
Become a member and join over 1 million active investors
or
Already have an account? Log in

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

MarketScreener
United-States
MarketScreener Canada
Canada

MIDDLE EAST

MarketScreener Saudi Arabia
Saudi Arabia
MarketScreener UAE Emirates
United Arab Emirates

EUROPE

Zonebourse
France
MarketScreener Deutschland
Deutschland
Zonebourse Suisse
Suisse
MarketScreener Schweiz
Schweiz
MarketScreener Italia
Italia
MarketScreener Österreich
Österreich
MarketScreener België
België
MarketScreener Nederland
Nederland
MarketScreener España
España
MarketScreener Sverige
Sverige
MarketScreener UK
United Kingdom

APAC

MarketScreener Australia
Australia
MarketScreener India
India
MarketScreener Hong Kong
Hong Kong